Medinotec designs, manufactures, and distributes balloon catheter and airway dilation products for cardiovascular and respiratory procedures. The company operates through its subsidiary, DISA Medinotec, and maintains manufacturing facilities in South Africa. Its core proprietary portfolio includes the Trachealator for airway stenosis, the Outflo balloon catheter for heart valve procedures, and Cape Cross coronary catheters. Medinotec operates a dual business model: manufacturing its own medical devices and distributing third-party cardiology and renal dialysis products. The company prioritizes its proprietary products because they offer higher margins compared to third-party distribution. Medinotec sells to hospitals and healthcare providers primarily through distributor relationships rather than a direct sales force. While South Africa remains the company's primary market, the growth strategy emphasizes geographic expansion into the U.S. and Europe. This expansion depends on securing regulatory approvals such as FDA 510(k) clearance and CE/MDR certification. Medinotec aims to scale by increasing procedure volumes in regulated markets where its products can command higher pricing. The company also develops new devices for respiratory, nasal, and gynecological applications to expand its addressable market. Success relies on building international distributor networks to cover the fixed costs associated with R&D and regulatory compliance.